A BioPharma Insights Company uses AlphaSense to Get Granular on Industry Insights
An unnamed leading biopharmaceutical insights company found that external platforms gave consensus financial projections but lacked methodological detail and had limited searchability. After adopting AlphaSense and Expert Insights, its clinical pharmacy director gained access to individual investor reports with transparent projection methodologies and expert interviews with key opinion leaders, enabling faster, more informed decisions and improved financial projections. The director is quoted calling the combined platform "not just a 'nice-to-have.' It's a necessity," crediting it with helping raise customer satisfaction and renewals.
The customer is anonymised in AlphaSense’s own case study — not withheld by us.
AlphaSense is an AI-powered search platform over premium business documents, earnings calls, filings and expert-network transcripts, used by pharma competitive-intelligence and business-development teams.
This sits in the Data Providers stage of the AI use-case lifecycle: Named examples from the real-world-data, claims and competitive-intelligence providers pharma AI systems are trained on, benchmarked against, or run inside of.
Published by AlphaSense on its own site — read the original case study on alpha-sense.com ↗
Related use cases
- 013M overcomes information overload with AlphaSense
- 02AlphaSense gives 3T a "one-stop-shop" to accelerate their research
- 03Arogyam Health Intelligence Chooses AlphaSense for Fast, Money-Saving Intelligence
- 04A biotech investor taps internal and external content for insights
- 05Cardinal Health accelerates their research process
- 06Emirates NBD Capital Accelerates Deal Execution with AlphaSense